Influenza Hemagglutinin (HA) Peptide: High-Purity Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic epitope tag widely used for the detection, purification, and elution of HA-tagged proteins in molecular biology. (APExBIO product page) It exhibits high solubility in water (≥46.2 mg/mL), ethanol (≥100.4 mg/mL), and DMSO (≥55.1 mg/mL), supporting flexible experimental design. The peptide's competitive binding to anti-HA antibodies enables rapid and specific elution of HA-fusion proteins in immunoprecipitation assays. High purity (>98%) is confirmed by HPLC and mass spectrometry, ensuring reproducibility. These properties have been benchmarked in workflows for protein-protein interaction and exosome pathway studies (Wei et al., 2021).

Biological Rationale

Epitope tags are short peptide sequences engineered onto recombinant proteins to facilitate their identification, purification, and interaction analysis. The Influenza Hemagglutinin (HA) Peptide, derived from the human influenza virus hemagglutinin protein, is a canonical example of such tags. Its sequence (YPYDVPDYA) represents the immunodominant region recognized by anti-HA monoclonal antibodies (related article). This enables robust, antibody-based detection and affinity purification. The HA tag is routinely used in studies requiring precise protein localization, quantification, and interaction profiling. Its specificity and compatibility with common biochemical reagents have made it a standard in molecular biology and cell biology research pipelines. Exosome pathway research, for example, leverages the HA tag to track tagged protein cargoes during vesicle biogenesis (Wei et al., 2021).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide acts as a competitive ligand for anti-HA antibodies. When fused to a target protein, it presents the YPYDVPDYA epitope, enabling immunodetection or affinity purification. During immunoprecipitation, anti-HA magnetic beads or conventional antibodies selectively capture HA-tagged fusion proteins. The addition of excess synthetic HA peptide (e.g., APExBIO’s A6004) disrupts this interaction, competitively eluting the tagged protein from the antibody (see related article). This mechanism is governed by the peptide's affinity and the concentration-dependent equilibrium between the immobilized antibody and the free peptide. The process is highly specific and does not disrupt endogenous protein complexes, allowing the study of protein-protein interactions and post-translational modifications. The HA tag’s small size minimizes interference with protein folding and function, in contrast to larger tags such as GFP or MBP.

Evidence & Benchmarks

• HA-tagged proteins can be quantitatively eluted from anti-HA affinity matrices using 0.1–1 mg/mL HA peptide in PBS at 4°C for 30 min (Wei et al., 2021).
• The synthetic HA peptide (A6004) achieves >98% purity, as confirmed by HPLC and MS analysis under standard buffer conditions (APExBIO).
• Solubility benchmarks: ≥46.2 mg/mL in water, ≥100.4 mg/mL in ethanol, ≥55.1 mg/mL in DMSO, at room temperature (25°C) (APExBIO).
• HA peptide-based elution preserves native protein complexes, as validated in exosome and vesicle trafficking studies (Wei et al., 2021).
• Long-term storage stability is optimal at -20°C desiccated; peptide solutions show reduced stability beyond one week at 4°C (APExBIO).

Applications, Limits & Misconceptions

The HA tag is extensively used for:

• Protein-protein interaction studies: Enables co-immunoprecipitation and mapping of protein complexes.
• Protein localization: Visualized by immunofluorescence microscopy using anti-HA antibodies.
• Protein purification: Facilitates single-step affinity purification of tagged proteins.
• Exosome and vesicle trafficking: Detects tagged proteins within multivesicular endosomes and exosomes (Wei et al., 2021).

For a broader discussion of advanced applications, see the article "Influenza Hemagglutinin (HA) Peptide: Precision Tag for Exosome Research", which this article updates by providing recent benchmarks and expanded troubleshooting for protein elution workflows.

Common Pitfalls or Misconceptions

• Not suitable for in vivo therapeutic use. The HA peptide is validated for research use only.
• Over-concentration may cause non-specific elution. Excess peptide (>5 mg/mL) can disrupt weakly bound contaminants.
• Does not work with denatured proteins. The anti-HA antibody requires epitope accessibility, which is lost in harsh denaturing conditions.
• Sequence variants can impair binding. Mutations or truncations in the HA tag reduce antibody recognition.
• Not a substitute for protein folding quality control. The HA tag does not ensure correct folding or activity of the fusion protein.

Workflow Integration & Parameters

The HA peptide integrates seamlessly with standard immunoprecipitation (IP), co-IP, and affinity purification protocols. For elution, recommended peptide concentrations are 0.1–1 mg/mL in PBS or Tris-buffered saline, incubated at 4°C for 20–60 min. The high solubility allows use in aqueous or organic buffers, accommodating proteins with diverse solubility profiles. For best results, prepare fresh peptide solutions immediately before use and avoid repeated freeze-thaw cycles. APExBIO’s A6004 peptide is supplied lyophilized and should be stored desiccated at -20°C. For a step-by-step workflow, see this guide, which this dossier extends by providing updated purity and solubility parameters.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (APExBIO A6004) remains a gold standard for molecular biology peptide tags. Its combination of high purity, robust solubility, and validated specificity underpins reproducible results in protein detection, purification, and interaction studies. Ongoing research in exosome biogenesis and protein trafficking continues to leverage HA-tagged constructs, with the synthetic peptide facilitating precise and gentle protein elution (Wei et al., 2021). For researchers requiring a dependable, well-characterized epitope tag, the HA peptide represents a best-in-class solution.

For detailed product specifications and ordering information, visit the APExBIO Influenza Hemagglutinin (HA) Peptide product page.